3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Terminated 1 |
Follow ronacaleret: new trials by email Literature Review of ronacaleret trials Research Report on ronacaleret
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret) Ronacaleret 100 mg, Ronacaleret 400 mg, Plerixafor - Transplantation, Stem Cell | Phase 1 | Completed | GlaxoSmithKline | 24 | 2012-11-02 | 2017-06-07 |
| An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers Ronacaleret (100mg tablet), Placebo - Bone Marrow Transplantation | Phase 1 | Completed | GlaxoSmithKline | 39 | 2011-10-27 | 2017-06-20 |
| To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females Ronacaleret - Osteoporosis | Phase 1 | Completed | GlaxoSmithKline | 32 | 2008-02-01 | 2016-05-02 |
| A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. Ronacaleret, Teriparatide, Alendronate - Osteoporosis | Phase 2 | Terminated | GlaxoSmithKline | 564 | 2007-05-14 | 2017-11-07 |
Osteoporosis (2)
GlaxoSmithKline (4)
United States (4) · Argentina (1) · Australia (1) · Belgium (1) · Denmark (1) · Germany (1) · Hong Kong (1) · Mexico (1) · Norway (1) · Poland (1) · Russia (1) · South Africa (1) · South Korea (1) · Spain (1)